Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 178.00
-1.50 (-0.84%)
At close: Sep 3, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 9.41 billion as of September 3, 2026. Its market cap has increased by 10.94% in one year.
Market Cap
9.41B
Enterprise Value
9.12B
Revenue
1.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
178.00
ChartMarket Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 9.41B, an increase of 350.11%. That is a compound annual growth rate of 13.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 9.41B | 64.17% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 7.66B |
| Libo Pharma | 2.25B |
| TEH SENG Pharmaceutical Mfg. | 2.14B |
| Gin Hwa Biotech Incorporation | 1.96B |
| Anbogen Therapeutics | 1.73B |
| Timing Pharmaceutial | 1.63B |
| TSA International | 1.56B |
| Anya Biopharm | 1.54B |